These in vitro observations were substantiated by our in vivo study where Nano-DOX treated-4T1 tumor xenografts displayed markedly increased infiltration and activation of CD4+ and CD8+ T cells (marked by CD69) and diminished infiltration of suppressive Treg cells (marked by foxp3) (Fig. 11j). The gene discussed is CD8A; the disease is neoplasm.